Total Medical devices industry M&A deals worth $1bn were announced globally in May 2022, led by ConMed’s $255m acquisition of In2Bones Global, according to GlobalData’s deals database.
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
The value marked a decrease of 32% over the previous month of $1.47bn and a drop of 86.6% when compared with the last 12-month average, which stood at $7.47bn.
Comparing M&A deals value in different regions of the globe, Asia-Pacific held the top position, with total announced deals in the period worth $554.65m. At the country level, the US topped the list in terms of deal value at $265m.
In terms of volumes, North America emerged as the top region for Medical devices industry M&A deals globally, followed by Europe and then Asia-Pacific.
The top country in terms of M&A deals activity in May 2022 was the US with 16 deals, followed by the Sweden with three and Canada with three.
In 2022, as of May, Medical devices M&A deals worth $9.75bn were announced globally, marking an increase of 72.1% year on year.
Medical devices industry M&A deals in May 2022: Top deals
The top five M&A deals accounted for 82.2% of the overall value during May 2022.
The combined value of the top five Medical devices M&A deals stood at $825.74m, against the overall value of $1bn recorded for the month.
The top five Medical devices industry M&A deals of May 2022 tracked by GlobalData were:
1) ConMed $255m acquisition deal with In2Bones Global
2) The $227.93m acquisition of 57.5% stake in Allm by DeNA
3) Straumann $138.06m acquisition deal with SunshineSmile
4) The $108.2m acquisition of Zhejiang Longterm Medical Technology by Winner Medical Group
5) Winner Medical Group $96.54m acquisition deal for 65.55% stake with Hunan Pingan Medical Device Technology